Clinical trial
The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically…
NCT00351663 · Shaare Zedek Medical Center, Other · Completed
Key facts
| NCT number | NCT00351663 |
|---|---|
| Title | The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients |
| Official title | Prospective Randomised Study of the Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients |
| Lead sponsor | Shaare Zedek Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Venous Thrombosis, Critical Illness |
| Intervention type | Drug |
| Interventions | Enoxaparine |
| Enrollment | 39 |
| Start date | Feb 1, 2007 |
| Primary completion | Apr 1, 2014 |
| Completion | Sep 1, 2015 |
| First posted | Jul 13, 2006 |
| Last update posted | Apr 20, 2016 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: